Metatron approved investors can acquire Series B shares in blocks of various sizes.  The first round investors will receive the highest discount currently at 60% to common shares.. Series B shares can only be redeemed through the Company. Series B shares are immune to any potential reverse splits proof and will convert at 1 B share to 50,000 common shares.

Investments will be used towards the development and growth of various apps and products including Cannabiods, Buzzlink, and Vaporizer apps. As well as complete our entertainment crowdfunding joint venture with Circa Pictures (OTC:CPPD). The in- app technology used for Circa platform is already developed and in the market with some of our apps and we expect with funding to release Circa’s app and platform Spring 2017.

Cannaboids is an Organic Nutraceuticals Portal, designed for medical marijuana patients to have the resources to find the latest CBD news and connect to legal dispensaries and has been release on iTunes and Google Play in beta.

Buzzlink is a business to business platform using apps and website portals to provide e- commerce solutions for small business’s including dispensaries. Buzzlink is expected to launch spring of 2017 and will be an exciting place for companies to find products, manage inventory, acquire customers and discover advertising opportunities.

Please visit Patriotic for information on her lawsuit against the liberal media machine and donate to her cause.

Apple has approved a version of our secure chat app and it is now in beta.

The Company has experience in developing over 2000+ mobile applications for top tier clients in the past years with over $3.6 million in sales and millions in downloads.

People interested, can view and download our current live apps focused on health and wellness, cannabis, and message encryption by visiting the app stores below. We plan to update these apps in our upcoming relaunch, and will be adding a more to our list.


Google Play:

Forward-Looking Statements: Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results of the specific items described in this release, and the company’s operations generally, to differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company’s need for additional financing, which is not assured and which may result in dilution of shareholders, the company’s status as a small company with a limited operating history, dependence on third parties and the continuing popularity of the iOS operating system, general market and economic conditions, technical factors, receipt of revenues, and other factors, many of which are beyond the control of the company. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements, and we disclaim any obligation to update information contained in any forward looking statement. Metatron retained Global Discovery Group Inc. for $30,500 for consulting services, CSC Partners for $1,500, Bas1 for $2501 and the company retained Pacific Equity Alliance LLC by issuing Integrative Business Alliance LLC 100m rule 144 for 1 year consulting services. Metatron does not grow, sell or distribute any substances that violate United States Law or the Controlled Substances Act.

Subscribe To Our Newsletter For The Latest Updates

Subscribe To Our Newsletter For The Latest Updates

Join our mailing list to receive the latest news and updates from Metatron, Inc.

You have Successfully Subscribed!